Search research articles
Contact Us
Filters
Showing results (141-150 of 202) with videos related to
Page
of 21
Sort By:
Urologic Oncology
|
June 19, 2016
Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer
Edmund C P Chedgy, James Douglas, Jonathan L Wright, et al.
The Journal of Urology
|
September 26, 2014
Clinical outcomes of cT1 micropapillary bladder cancer
Daniel L Willis, Mario I Fernandez, Rian J Dickstein, et al.
Surgical Innovation
|
March 21, 2018
Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical Cystectomy
Janet Baack Kukreja, Qiuling Shi, Courtney M Chang, et al.
Urologic Oncology
|
February 10, 2021
Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project
Gang Wang, Peter C Black, Peter J Goebell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 4, 2017
Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience
Beatrice J Edwards, Ming Sun, Xiaotao Zhang, et al.
The Journal of Urology
|
June 29, 2021
Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy
Patrick J Hensley, Kelly K Bree, Matthew T Campbell, et al.
The Journal of Urology
|
August 10, 2021
Reply by Authors
Patrick J Hensley, Kelly K Bree, Matthew T Campbell, et al.
The Journal of Urology
|
September 25, 2019
The Role of Fluorescence In Situ Hybridization for Predicting Recurrence after Adjuvant bacillus Calmette-Guérin in Patients with Intermediate and High Risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data
Esmée I M L Liem, Jorg R Oddens, Robin W M Vernooij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy
Kelly N Blehm, Philippe E Spiess, Jolanta E Bondaruk, et al.
The Journal of Urology
|
November 25, 2003
Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population
Ken-Ryu Han, Ivar Bleumer, Allan J Pantuck, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 202) with videos related to
Sort By:
Page
of 21
Urologic Oncology
|
June 19, 2016
Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer
Edmund C P Chedgy, James Douglas, Jonathan L Wright, et al.
The Journal of Urology
|
September 26, 2014
Clinical outcomes of cT1 micropapillary bladder cancer
Daniel L Willis, Mario I Fernandez, Rian J Dickstein, et al.
Surgical Innovation
|
March 21, 2018
Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical Cystectomy
Janet Baack Kukreja, Qiuling Shi, Courtney M Chang, et al.
Urologic Oncology
|
February 10, 2021
Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project
Gang Wang, Peter C Black, Peter J Goebell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 4, 2017
Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience
Beatrice J Edwards, Ming Sun, Xiaotao Zhang, et al.
The Journal of Urology
|
June 29, 2021
Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy
Patrick J Hensley, Kelly K Bree, Matthew T Campbell, et al.
The Journal of Urology
|
August 10, 2021
Reply by Authors
Patrick J Hensley, Kelly K Bree, Matthew T Campbell, et al.
The Journal of Urology
|
September 25, 2019
The Role of Fluorescence In Situ Hybridization for Predicting Recurrence after Adjuvant bacillus Calmette-Guérin in Patients with Intermediate and High Risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data
Esmée I M L Liem, Jorg R Oddens, Robin W M Vernooij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy
Kelly N Blehm, Philippe E Spiess, Jolanta E Bondaruk, et al.
The Journal of Urology
|
November 25, 2003
Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population
Ken-Ryu Han, Ivar Bleumer, Allan J Pantuck, et al.
Page
of 21